首站-论文投稿智能助手
典型文献
Prevalence and Factors Associated with Concomitant Chinese Medicine Use by Rheumatoid Arthritis Patients in A Multi-Ethnic Asian Population
文献摘要:
Objective:To determine the prevalence,factors associated with and patterns of concomitant Chinese medicine(CM)with Western treatment use among patients with rheumatoid arthritis(RA)in a tertiary referral centre(Singapore General Hospital)in Singapore.Methods:We conducted a cross-sectional interviewer-administered survey of a consecutive sample of patients with RA in Singapore General Hospital centre regarding their CM use including data on patient demographics,disease characteristics,concomitant use of CM and reasons,concerns and disclosure patterns from March to August 2015.Univariate and multivariate logistic regression analyses were performed to determine the associations of CM use.Results:Prevalence of CM use among the 258 patients surveyed(male:female 42:216;Chinese:Malay:Indian 191:29:34;mean age:61 years;mean duration of RA:10 years)was 46.1%(119/258).On multivariate analysis,Chinese ethnicity(OR,95%CI:4.11,1.49-11.36),Chinese speakers(OR,95%CI:2.35,1.03-5.54),middle-income group(OR,95%CI:2.53,1.01-6.31)and greater learned helplessness(OR,95%CI:1.13,1.04-1.22)were significantly associated with CM use.More CM users disclosed their CM use to CM physicians(87.3%,96/110),sought advice from them on treatment interactions(59.4%,57/96)and how best to combine treatments(49.0%,47/96)than did so with rheumatologists(42.0%,50/119;40.0%,20/50;and 42.0%,21/50,respectively).Forty-two percentage(29/69)of patients who concealed CM use from rheumatologists because their rheumatologists did not specifically enquire about CM use.Conclusions:Concomitant CM use among patients with RA treated in a tertiary referral centre in Singapore is high but voluntary disclosure is low.The associations identified can help doctors identify and enquire about CM use,minimizing potential adverse interactions.
文献关键词:
作者姓名:
HUANG You-yi;XIN Xiao-hui;Rehena Sultana;Julian Thumboo;FONG Kok Yong
作者机构:
Duke-NUS Medical School,Singapore;Department of Rheumatology and Immunology,Singapore General Hospital,Singapore;Medicine Academic Clinical Program,Division of Medicine,Singapore General Hospital,Singapore;Centre for Quantitative Medicine,Duke-NUS Medical School,Singapore
引用格式:
[1]HUANG You-yi;XIN Xiao-hui;Rehena Sultana;Julian Thumboo;FONG Kok Yong-.Prevalence and Factors Associated with Concomitant Chinese Medicine Use by Rheumatoid Arthritis Patients in A Multi-Ethnic Asian Population)[J].中国结合医学杂志(英文版),2022(03):223-228
A类:
interviewer,Malay,helplessness,rheumatologists,enquire
B类:
Prevalence,Factors,Associated,Concomitant,Chinese,Medicine,Use,by,Rheumatoid,Arthritis,Patients,Multi,Ethnic,Asian,Population,Objective,To,determine,prevalence,factors,associated,patterns,concomitant,medicine,CM,among,patients,rheumatoid,arthritis,RA,tertiary,referral,centre,Singapore,General,Hospital,Methods,conducted,cross,sectional,administered,consecutive,sample,regarding,their,including,data,demographics,disease,characteristics,reasons,concerns,disclosure,from,March,August,Univariate,multivariate,logistic,regression,analyses,were,performed,associations,Results,surveyed,female,Indian,mean,years,duration,was,On,analysis,ethnicity,speakers,middle,income,group,greater,learned,significantly,More,users,disclosed,physicians,sought,advice,them,interactions,how,best,combine,treatments,than,did,respectively,Forty,two,percentage,who,concealed,because,not,specifically,about,Conclusions,treated,high,but,voluntary,low,identified,doctors,identify,minimizing,potential,adverse
AB值:
0.529588
相似文献
A Case Series of Olfactory Dysfunction in Imported COVID-19 Patients: A 12-Month Follow-Up Study
WANG Ni;YANG Ming Bo;YANG Pu Ye;CHEN Ren Bo;HUANG Fei;SHI Nan Nan;MA Yan;ZHANG Yan;XU You;LIU Si Hong;LU Heng Yi;FU Qing Qing;FAN Yi Pin;KAN Hong Min;WANG Xiao Hong;GUO Ya Ling-National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206,China;Hepatology Department of TCM,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Integrated Chinese and Western Medicine,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Infection,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700, China
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Liu Zuojing;Zhu Shiwei;He Meibo;Li Mo;Wei Hui;Zhang Lu;Sun Qinghua;Jia Qiong;Hu Nan;Fang Yuan;Song Lijin;Zhou Chen;Tao Heqing;Y Kao John;Zhu Huaiqiu;Owyang Chung;Duan Liping-Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing 100191, China;Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing 100191, China;Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China;Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 6520 MSRB I, SPC 5682, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
Gui Yinli;Bai Wei;Xu Jian;Duan Xinwang;Zhan Feng;Zhao Chen;Jiang Zhenyu;Li Zhijun;Wu Lijun;Liu Shengyun;Yang Min;Wei Wei;Wang Ziqian;Zhao Jiuliang;Wang Qian;Leng Xiaomei;Tian Xinping;Li Mengtao;Zhao Yan;Zeng Xiaofeng;CSTAR co-authors-Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, The People’s Hospital of Zhengzhou, Zhengzhou, Henan 450003, China;Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Rheumatology, The Bethune First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Rheumatology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China;Department of Rheumatology, The People’s Hospital of Xinjiang Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Rheumatology, Tianjin Medical University General Hospital, Tianjin 300052, China
A New Coronavirus Estimation Global Score for Predicting Mortality During Hospitalization in Patients with COVID-19
Zeng Hesong;He Xingwei;Liu Wanjun;Kan Jing;He Liqun;Zhao Jinhe;Chen Cynthia;Zhang Junjie;Chen Shaoliang-Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei 430030, China;Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, China;Division of Cardiology, Wuhan First Hospital, Wuhan, Hubei 430022, China;Division of Cardiology, Tianyou Hospital affiliated to Wuhan University of Science & Technology, Wuhan, Hubei 430064, China;Mailman School of Public Health, Columbia University, New York, New York 10027, USA;College of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 210002, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。